PRORADNOR-ReIRNCT07922967
Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Tolerability -patient-reported dysphagia measured with EORTC QLQ-HN43 dysphagia scale
Timeframe: From enrollment untill 6 Months post-treatment
Secondary (5)
Loco-regional control
Disease free survival
Overall survival
Health-related quality of life measured with EORTC QLQ-C30
Adverse events
Arms and interventions
Recurrance/second primay disease of HNC
Radiation: Proton radiotherapy
Sites
4 sites in 1 country